Genetic and epigenetic studies for determining molecular targets of natural product anticancer agents

Current Cancer Drug Targets

Volumn 13, Issue 5, 2013, Pages 506-518

  Wang, Yujiong ^a,b   Li, Yong ^a,b   Liu, Xiaoming ^a,b   Cho, William C S ^c  

^a Utilization of Special Biological Resources in Western China   (China)

^b NINGXIA UNIVERSITY   (China)

^c QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Cancer stem cells; Epigenetics; Genetics; MicroRNA; Natural product

Indexed keywords

ANTINEOPLASTIC AGENT; CURCUMIN; DNA METHYLTRANSFERASE 1; ENTINOSTAT; EPIGALLOCATECHIN GALLATE; FLUOROURACIL; GENISTEIN; I KAPPA B ALPHA; ISOFLAVONE DERIVATIVE; ISOFLAVONE GENISTEIN; MICRORNA; MICRORNA 200; MICRORNA 21; NANOPARTICLE; NATURAL PRODUCT; OXALIPLATIN; PACLITAXEL; PROTEIN BCL 2; RESVERATROL; SULFORAPHANE; TRANSCRIPTION FACTOR AP 1; TRIPTOLIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENETICS; CANCER GROWTH; CANCER PREVENTION; CANCER STEM CELL; CARCINOGENESIS; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; LOW DRUG DOSE; METASTASIS; NEOPLASM; NONHUMAN; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL PRODUCTS; EPIGENOMICS; GENE EXPRESSION PROFILING; GENETIC TESTING; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; PHYTOTHERAPY; TUMOR MARKERS, BIOLOGICAL;

EID: 84880711984     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/15680096113139990033     Document Type: Article

References (173)

1. Ellis, L.; Atadja, P. W.; Johnstone, R. W. Epigenetics in cancer: targeting chromatin modifications. Mol. Cancer Ther. 2009, 8, 1409-1420.
2. Esteller, M. Cancer Epigenetics for the 21st Century: What's Next? Genes Cancer 2011, 2, 604-606.
3. Anand, P.; Kunnumakkara, A. B.; Sundaram, C.; Harikumar, K. B.; Tharakan, S. T.; Lai, O. S.; Sung, B.; Aggarwal, B. B. Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res. 2008, 25, 2097-2116.
4. Issa, J. P. Cancer prevention: epigenetics steps up to the plate. Cancer Prev. (Phila) 2008, 1, 219-222.
5. Esteller, M. Epigenetics in cancer. N. Engl. J. Med. 2008, 358, 1148-1159.
6. Herceg, Z. Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 2007, 22, 91-103.
7. Meyerson, M.; Gabriel, S.; Getz, G. Advances in understanding cancer genomes through second-generation sequencing. Nat. Rev. Genet. 2010, 11, 685-696.
8. de Bono, J. S.; Ashworth, A. Translating cancer research into targeted therapeutics. Nature 2010, 467, 543-549.
9. Suter, M. A.; Aagaard-Tillery, K. M. Environmental influences on epigenetic profiles. Semin. Reprod. Med. 2009, 27, 380-390.
10. Li, Y.; Tollefsbol, T. O. Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. Curr. Med. Chem. 2010, 17, 2141-2151.
11. Paluszczak, J.; Krajka-Kuzniak, V.; Baer-Dubowska, W. The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicol. Lett. 2010, 192, 119-125.
12. Parker, L. P.; Taylor, D. D.; Kesterson, J.; Metzinger, D. S.; Gercel-Taylor, C. Modulation of microRNA associated with ovarian cancer cells by genistein. Eur. J. Gynaecol. Oncol. 2009, 30, 616-621.
13. Li, Y.; VandenBoom, T. G., Kong, D.; Wang, Z.; Ali, S.; Philip, P. A.; Sarkar, F. H. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res. 2009, 69, 6704-6712.
14. Sun, Q.; Cong, R.; Yan, H.; Gu, H.; Zeng, Y.; Liu, N.; Chen, J.; Wang, B. Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. Oncol. Rep. 2009, 22, 563-567.
15. Dubrovska, A.; Elliott, J.; Salamone, R. J.; Kim, S.; Aimone, L. J.; Walker, J. R.; Watson, J.; Sauveur-Michel, M.; Garcia-Echeverria, C.; Cho, C. Y.; Reddy, V. A.; Schultz, P. G. Combination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinoma. Clin. Cancer Res. 2010, 16, 5692-5702.
16. Wilken, R.; Veena, M. S.; Wang, M. B.; Srivatsan, E. S. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol. Cancer 2011, 10, 12.
17. Newman, D. J.; Cragg, G. M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012, 75, 311-335.
18. Gullett, N. P.; Ruhul Amin, A. R.; Bayraktar, S.; Pezzuto, J. M.; Shin, D. M.; Khuri, F. R.; Aggarwal, B. B.; Surh, Y. J.; Kucuk, O. Cancer prevention with natural compounds. Semin. Oncol. 2010, 37, 258-281.
19. Tsuda, H.; Ohshima, Y.; Nomoto, H.; Fujita, K.; Matsuda, E.; Iigo, M.; Takasuka, N.; Moore, M. A. Cancer prevention by natural compounds. Drug metabolism and pharmacokinetics. Drug Metab. Pharmacokinet. 2004, 19, 245-263.
20. Meeran, S. M.; Ahmed, A.; Tollefsbol, T. O. Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clin. Epigenetics 2010, 1, 101-116.
21. Aravindaram, K.; Yang, N. S. Anti-inflammatory plant natural products for cancer therapy. Planta Med. 2010, 76, 1103-1117.
22. Subramanian, B.; Nakeff, A.; Tenney, K.; Crews, P.; Gunatilaka, L.; Valeriote, F. A new paradigm for the development of anticancer agents from natural products. J. Exp. Ther. Oncol. 2006, 5, 195-204.
23. Parasramka, M. A.; Ho, E.; Williams, D. E.; Dashwood, R. H. MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals. Mol. Carcinog. 2012, 51, 213-230.
24. Hauser, A. T.; Jung, M. Targeting epigenetic mechanisms: potential of natural products in cancer chemoprevention. Planta Med. 2008, 74, 1593-1601.
25. Li, Y.; Kong, D.; Wang, Z.; Sarkar, F. H. Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharm. Res. 2010, 27, 1027-1041.
26. Li, Y.; Wicha, M. S.; Schwartz, J.; Sun, D. Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds. J. Nutr. Biochem. 2011, 22, 799-806.
27. Liu, Z.; Ma, L.; Zhou, G. B. The main anticancer bullets of the Chinese medicinal herb, thunder god vine. Molecules 2011, 16, 5283-5297.
28. Zhao, F.; Chen, Y.; Li, R.; Liu, Y.; Wen, L.; Zhang, C. Triptolide alters histone H3K9 and H3K27 methylation state and induces G0/G1 arrest and caspase-dependent apoptosis in multiple myeloma in vitro. Toxicology 2010, 267, 70-79.
29. Pan, J. RNA polymerase - an important molecular target of triptolide in cancer cells. Cancer Lett. 2010, 292, 149-152.
30. Gong, H.; Shen, P.; Jin, L.; Xing, C.; Tang, F. Herapeutic effects of Lycium barbarum polysaccharide (LBP) on irradiation or chemotherapy-induced myelosuppressive mice. Cancer Biother. Radiopharm. 2005, 20, 155-162.
31. Zhang, Z.; Liu, X.; Wu, T.; Liu, J.; Zhang, X.; Yang, X.; Goodheart, M. J.; Engelhardt, J. F.; Wang, Y. Selective suppression of cervical cancer Hela cells by 2-O-beta-D-glucopyranosyl-L-ascorbic acid isolated from the fruit of Lycium barbarum L. Cell Biol. Toxicol. 2010, 27, 107-121.
32. Zhang, Z.; Liu, X.; Zhang, X.; Liu, J.; Hao, Y.; Yang, X.; Wang, Y. Comparative evaluation of the antioxidant effects of the natural vitamin C analog 2-O-beta-D-glucopyranosyl-L-ascorbic acid isolated from Goji berry fruit. Arch. Pharm. Res. 2011, 34, 801-810.
33. Luo, Q.; Li, Z.; Yan, J.; Zhu, F.; Xu, R. J.; Cai, Y. Z. Lycium barbarum polysaccharides induce apoptosis in human prostate cancer cells and inhibits prostate cancer growth in a xenograft mouse model of human prostate cancer. J. Med. Food 2009, 12, 695-703.
34. Han, K. C.; Wong, W. C.; Benzie, I. F. Genoprotective effects of green tea (Camellia sinensis) in human subjects: results of a controlled supplementation trial. Br. J. Nutr. 2011, 105, 171-179.
35. Khan, N.; Mukhtar, H. Cancer and metastasis: prevention and treatment by green tea. Cancer Metastasis Rev. 2010, 29, 435-445.
36. Graham, H. N. Green tea composition, consumption, and polyphenol chemistry. Prev. Med. 1992, 21, 334-350.
37. Balentine, D. A.; Wiseman, S. A.; Bouwens, L. C. The chemistry of tea flavonoids. Crit. Rev. Food Sci. Nutr. 1997, 37, 693-704.
38. Lin, J. K. Cancer chemoprevention by tea polyphenols through modulating signal transduction pathways. Arch Pharm. Res. 2002, 25, 561-571.
39. Berletch, J. B.; Liu, C.; Love, W. K.; Andrews, L. G.; Katiyar, S. K.; Tollefsbol, T. O. Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. J. Cell Biochem. 2008, 103, 509-519.
40. Gu, B.; Ding, Q.; Xia, G.; Fang, Z. EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression. Oncol. Rep. 2009, 21, 635-640.
41. Balasubramanian, S.; Adhikary, G.; Eckert, R. L. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival. Carcinogenesis 2010, 31, 496-503.
42. Chen, D.; Pamu, S.; Cui, Q.; Chan, T. H.; Dou, Q. P. Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells. Bioorg. Med. Chem., 2012, 20, 3031-3037.
43. Kanai, M.; Yoshimura, K.; Asada, M.; Imaizumi, A.; Suzuki, C.; Matsumoto, S.; Nishimura, T.; Mori, Y.; Masui, T.; Kawaguchi, Y.; Yanagihara, K.; Yazumi, S.; Chiba, T.; Guha, S.; Aggarwal, B. B. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother. Pharmacol. 2011, 68, 157-164.
44. Cheng, A. L.; Hsu, C. H.; Lin, J. K.; Hsu, M. M.; Ho, Y. F.; Shen, T. S.; Ko, J. Y.; Lin, J. T.; Lin, B. R.; Ming-Shiang, W.; Yu, H. S.; Jee, S. H.; Chen, G. S.; Chen, T. M.; Chen, C. A.; Lai, M. K.; Pu, Y. S.; Pan, M. H.; Wang, Y. J.; Tsai, C. C.; Hsieh, C. Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001, 21, 2895-2900.
45. Wang, L.; Shen, Y.; Song, R.; Sun, Y.; Xu, J.; Xu, Q. An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells. Mol. Pharmacol. 2009, 76, 1238-1245.
46. Yang, J.; Cao, Y.; Sun, J.; Zhang, Y. Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells. Med. Oncol. 2010, 27, 1114-1118.
47. Fu, S.; Kurzrock, R. Development of curcumin as an epigenetic agent. Cancer 2010, 116, 4670-4676.
48. Anand, P.; Thomas, S. G.; Kunnumakkara, A. B.; Sundaram, C.; Harikumar, K. B.; Sung, B.; Tharakan, S. T.; Misra, K.; Priyadarsini, I. K.; Rajasekharan, K. N.; Aggarwal, B. B. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem. Pharmacol. 2008, 76, 1590-1611.
49. Reuter, S.; Eifes, S.; Dicato, M.; Aggarwal, B. B.; Diederich, M. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem. Pharmacol. 2008, 76, 1340-1351.
50. Liu, H. L.; Chen, Y.; Cui, G. H.; Zhou, J. F. Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation. Acta Pharmacol. Sin. 2005, 26, 603-609.
51. Yang, C. S.; Landau, J. M.; Huang, M. T.; Newmark, H. L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr. 2001, 21, 381-406.
52. Gu, Y.; Zhu, C. F.; Iwamoto, H.; Chen, J. S. Genistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis. World J. Gastroenterol. 2005, 11, 6512-6517.
53. Singh, A. V.; Franke, A. A.; Blackburn, G. L.; Zhou, J. R. Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis. Cancer Res. 2006, 66, 1851-1858.
54. Kikuno, N.; Shiina, H.; Urakami, S.; Kawamoto, K.; Hirata, H.; Tanaka, Y.; Majid, S.; Igawa, M.; Dahiya, R. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int. J. Cancer. 2008, 123, 552-560.
55. Bishayee, A. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev. Res. (Phila) 2009, 2, 409-418.
56. Mao, Q. Q.; Bai, Y.; Lin, Y. W.; Zheng, X. Y.; Qin, J.; Yang, K.; Xie, L. P. Resveratrol confers resistance against taxol via induction of cell cycle arrest in human cancer cell lines. Mol. Nutr. Food Res. 2010, 54, 1574-1584.
57. Liu, P. L.; Tsai, J. R.; Charles, A. L.; Hwang, J. J.; Chou, S. H.; Ping, Y. H.; Lin, F. Y.; Chen, Y. L.; Hung, C. Y.; Chen, W. C.; Chen, Y. H.; Chong, I. W. Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases. Mol. Nutr. Food Res. 2010, 54(Suppl 2), S196-S204.
58. Papoutsis, A. J.; Lamore, S. D.; Wondrak, G. T.; Selmin, O. I.; Romagnolo, D. F. Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells. J. Nutr. 2010, 140, 1607-1614.
59. Wang, R. H.; Zheng, Y.; Kim, H. S.; Xu, X.; Cao, L.; Luhasen, T.; Lee, M. H.; Xiao, C.; Vassilopoulos, A.; Chen, W.; Gardner, K.; Man, Y. G.; Hung, M. C.; Finkel, T.; Deng, C. X. Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis. Mol. Cell 2008, 32, 11-20.
60. Boily, G.; He, X. H.; Pearce, B.; Jardine, K.; McBurney, M. W. SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol. Oncogene 2009, 28, 2882-2893.
61. Cheung, K. L.; Kong, A. N. Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J. 2010, 12, 87-97.
62. Bryant, C. S.; Kumar, S.; Chamala, S.; Shah, J.; Pal, J.; Haider, M.; Seward, S.; Qazi, A. M.; Morris, R.; Semaan, A.; Shammas, M. A.; Steffes, C.; Potti, R. B.; Prasad, M.; Weaver, D. W.; Batchu, R. B. Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells. Mol. Cancer 2010, 9, 47.
63. Chinni, S. R.; Li, Y.; Upadhyay, S.; Koppolu, P. K.; Sarkar, F. H. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 2001, 20, 2927-2936.
64. Yen, T. T.; Gill, A. M.; Frigeri, L. G.; Barsh, G. S.; Wolff, G. L. Obesity, diabetes, and neoplasia in yellow A(vy)/- mice: ectopic expression of the agouti gene. FASEB J. 1994, 8, 479-488.
65. Michaud, E. J.; van Vugt, M. J.; Bultman, S. J.; Sweet, H. O.; Davisson, M. T.; Woychik, R. P. Differential expression of a new dominant agouti allele (Aiapy) is correlated with methylation state and is influenced by parental lineage. Genes Dev. 1994, 8, 1463-1472.
66. Kotsopoulos, J.; Sohn, K. J.; Kim, Y. I. Postweaning dietary folate deficiency provided through childhood to puberty permanently increases genomic DNA methylation in adult rat liver. J. Nutr. 2008, 138, 703-709.
67. Dolinoy, D. C.; Weidman, J. R.; Waterland, R. A.; Jirtle, R. L. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ. Health Perspect. 2006, 114, 567-572.
68. Hardy, T. M.; Tollefsbol, T. O. Epigenetic diet: impact on the epigenome and cancer. Epigenomics 2011, 3, 503-518.
69. Hoffman, D. R.; Cornatzer, W. E.; Duerre, J. A. Relationship between tissue levels of S-adenosylmethionine, S-adenylhomocysteine, and transmethylation reactions. Can. J. Biochem. 1979, 57, 56-65.
70. Dalvai, M.; Bystricky, K. The role of histone modifications and variants in regulating gene expression in breast cancer. J. Mammary Gland Biol. Neoplasia 2010, 15, 19-33.
71. Ganesan, A.; Nolan, L.; Crabb, S. J.; Packham, G. Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discovery. Curr. Cancer Drug Targets 2009, 9, 963-981.
72. Fang, M. Z.; Wang, Y.; Ai, N.; Hou, Z.; Sun, Y.; Lu, H.; Welsh, W.; Yang, C. S. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 2003, 63, 7563-7570.
73. Fang, M.; Chen, D.; Yang, C. S. Dietary polyphenols may affect DNA methylation. J. Nutr. 2007, 137, 223S-228S.
74. Lee, A. H.; Fraser, M. L.; Meng, X.; Binns, C. W. Protective effects of green tea against prostate cancer. Expert review of anticancer therapy. Expert Rev. Anticancer Ther. 2006, 6, 507-513.
75. Gao, Z.; Xu, Z.; Hung, M. S.; Lin, Y. C.; Wang, T.; Gong, M.; Zhi, X.; Jablon, D. M.; You, L. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells. Anticancer Res. 2009, 29, 2025-2030.
76. Pandey, M.; Shukla, S.; Gupta, S. Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells. Int. J. Cancer 2010, 126, 2520-2533.
77. Kato, K.; Long, N. K.; Makita, H.; Toida, M.; Yamashita, T.; Hatakeyama, D.; Hara, A.; Mori, H.; Shibata, T. Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br. J. Cancer 2008, 99, 647-654.
78. Tachibana, H. Molecular basis for cancer chemoprevention by green tea polyphenol EGCG. Forum Nutr. 2009, 61, 156-169.
79. Johnson, I. T.; Belshaw, N. J. Environment, diet and CpG island methylation: epigenetic signals in gastrointestinal neoplasia. Food Chem. Toxicol. 2008, 46, 1346-1359.
80. Majid, S.; Kikuno, N.; Nelles, J.; Noonan, E.; Tanaka, Y.; Kawamoto, K.; Hirata, H.; Li, L. C.; Zhao, H.; Okino, S. T.; Place, R. F.; Pookot, D.; Dahiya, R. Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res. 2008, 68, 2736-2744.
81. King-Batoon, A.; Leszczynska, J. M.; Klein, C. B. Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ. Mol. Mutagen. 2008, 49, 36-45.
82. Majid, S.; Dar, A. A.; Ahmad, A. E.; Hirata, H.; Kawakami, K.; Shahryari, V.; Saini, S.; Tanaka, Y.; Dahiya, A. V.; Khatri, G.; Dahiya, R. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 2009, 30, 662-670.
83. Li, Y.; Liu, L.; Andrews, L. G.; Tollefsbol, T. O. Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms. Int. J. Cancer 2009, 125, 286-296.
84. Tang, W. Y.; Newbold, R.; Mardilovich, K.; Jefferson, W.; Cheng, R. Y.; Medvedovic, M.; Ho, S. M. Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. Endocrinology 2008, 149, 5922-5931.
85. Sun, M.; Estrov, Z.; Ji, Y.; Coombes, K. R.; Harris, D. H.; Kurzrock, R. Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol. Cancer Ther. 2008, 7, 464-473.
86. Bao, B.; Ali, S.; Banerjee, S.; Wang, Z.; Logna, F.; Azmi, A. S.; Kong, D.; Ahmad, A.; Li, Y.; Padhye, S.; Sarkar, F. H. Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Res. 2012, 72, 335-345.
87. Marcu, M. G.; Jung, Y. J.; Lee, S.; Chung, E. J.; Lee, M. J.; Trepel, J.; Neckers, L. Curcumin is an inhibitor of p300 histone acetylatransferase. Med. Chem. 2006, 2, 169-174.
88. Choi, K. C.; Jung, M. G.; Lee, Y. H.; Yoon, J. C.; Kwon, S. H.; Kang, H. B.; Kim, M. J.; Cha, J. H.; Kim, Y. J.; Jun, W. J.; Lee, J. M.; Yoon, H. G. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res. 2009, 69, 583-592.
89. Tsang, W. P.; Kwok, T. T. Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J. Nutr. Biochem. 2010, 21, 140-146.
90. Wang, H.; Bian, S.; Yang, C. S. Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1alpha. Carcinogenesis 2011, 32, 1881-1889.
91. Qin, W.; Zhu, W.; Shi, H.; Hewett, J. E.; Ruhlen, R. L.; MacDonald, R. S.; Rottinghaus, G. E.; Chen, Y. C.; Sauter, E. R. Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women. Nutr. Cancer 2009, 61, 238-244.
92. Salerno, E.; Scaglione, B. J.; Coffman, F. D.; Brown, B. D.; Baccarini, A.; Fernandes, H.; Marti, G.; Raveche, E. S. Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity. Mol. Cancer Ther. 2009, 8, 2684-2692.
93. Chen, Y.; Zaman, M. S.; Deng, G.; Majid, S.; Saini, S.; Liu, J.; Tanaka, Y.; Dahiya, R. MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev. Res. (Phila) 2011, 4, 76-86.
94. Rabiau, N.; Trraf, H. K.; Adjakly, M.; Bosviel, R.; Guy, L.; Fontana, L.; Bignon, Y. J.; Bernard-Gallon, D. J. Mirnas differentially expressed in prostate cancer cell lines after soy treatment. In Vivo, 2011, 25, 917-921.
95. Izzotti, A.; Calin, G. A.; Steele, V. E.; Cartiglia, C.; Longobardi, M.; Croce, C. M.; De Flora, S. Chemoprevention of cigarette smoke-induced alterations of MicroRNA expression in rat lungs. Cancer Prev. Res. (Phila) 2010, 3, 62-72.
96. Melkamu, T.; Zhang, X.; Tan, J.; Zeng, Y.; Kassie, F. Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol. Carcinogenesis 2010, 31, 252-258.
97. Beaver, L. M.; Yu, T. W.; Sokolowski, E. I.; Williams, D. E.; Dashwood, R. H.; Ho, E. 3,3'-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells. Toxicol. Appl. Pharmacol. 2012, 263, 345-351.
98. Banerjee, S.; Kong, D.; Wang, Z.; Bao, B.; Hillman, G. G.; Sarkar, F. H. Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic. Mutat. Res. 2011, 728, 47-66.
99. Lukiw, W. J.; Zhao, Y.; Cui, J. G. An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J. Biol. Chem. 2008, 283, 31315-31322.
100. Tili, E.; Michaille, J. J.; Adair, B.; Alder, H.; Limagne, E.; Taccioli, C.; Ferracin, M.; Delmas, D.; Latruffe, N.; Croce, C. M. Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. Carcinogenesis 2010, 31, 1561-1566.
101. Papoutsis, A. J.; Borg, J. L.; Selmin, O. I.; Romagnolo, D. F. BRCA-1 promoter hypermethylation and silencing induced by the aromatic hydrocarbon receptor-ligand TCDD are prevented by resveratrol in MCF-7 cells. J. Nutr. Biochem. 2012, 23, 1324-1332.
102. Yaseen, A.; Chen, S.; Hock, S.; Rosato, R.; Dent, P.; Dai, Y.; Grant, S. Resveratrol Sensitizes AML Cells to HDAC Inhibitors via ROS-Mediated Activation of the Extrinsic Apoptotic Pathway. Mol. Pharmacol. 2012, 82, 1030-1041.
103. Meeran, S. M.; Katiyar, S. K. Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front Biosci. 2008, 13, 2191-2202.
104. Traka, M.; Gasper, A. V.; Smith, J. A.; Hawkey, C. J.; Bao, Y.; Mithen, R. F. Transcriptome analysis of human colon Caco-2 cells exposed to sulforaphane. J. Nutr. 2005, 135, 1865-1872.
105. Ho, E.; Clarke, J. D.; Dashwood, R. H. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention. J. Nutr. 2009, 139, 2393-2396.
106. Myzak, M. C.; Tong, P.; Dashwood, W. M.; Dashwood, R. H.; Ho, E. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp. Biol. Med. (Maywood) 2007, 232, 227-234.
107. Dashwood, R. H.; Ho, E. Dietary agents as histone deacetylase inhibitors: sulforaphane and structurally related isothiocyanates. Nutr. Rev. 2008, 66 Suppl 1, S36-S38.
108. Myzak, M. C.; Ho, E.; Dashwood, R. H. Dietary agents as histone deacetylase inhibitors. Mol. Carcinog. 2006, 45, 443-446.
109. Messina, M.; Wu, A. H. Perspectives on the soy-breast cancer relation. Am. J. Clin. Nutr. 2009, 89, 1673S-1679S.
110. Bhamre, S.; Sahoo, D.; Tibshirani, R.; Dill, D. L.; Brooks, J. D. Temporal changes in gene expression induced by sulforaphane in human prostate cancer cells. Prostate 2009, 69, 181-190.
111. Telang, U.; Brazeau, D. A.; Morris, M. E. Comparison of the effects of phenethyl isothiocyanate and sulforaphane on gene expression in breast cancer and normal mammary epithelial cells. Exp. Biol. Med. (Maywood) 2009, 234, 287-295.
112. Myzak, M. C.; Karplus, P. A.; Chung, F. L.; Dashwood, R. H. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res. 2004, 64, 5767-5774.
113. Myzak, M. C.; Dashwood, W. M.; Orner, G. A.; Ho, E.; Dashwood, R. H. Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. FASEB J. 2006, 20, 506-508.
114. Balasubramanyam, K.; Varier, R. A.; Altaf, M.; Swaminathan, V.; Siddappa, N. B.; Ranga, U.; Kundu, T. K. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J. Biol. Chem. 2004, 279, 51163-51171.
115. Kang, S. K.; Cha, S. H.; Jeon, H. G. Curcumin-induced histone hypoacetylation enhances caspase-3-dependent glioma cell death and neurogenesis of neural progenitor cells. Stem Cells Dev. 2006, 15, 165-174.
116. Chen, Y.; Shu, W.; Chen, W.; Wu, Q.; Liu, H.; Cui, G. Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells. Basic Clin. Pharmacol. Toxicol. 2007, 101, 427-433.
117. Izzotti, A.; Cartiglia, C.; Steele, V. E.; De Flora, S. MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis. Mutat. Res. 2012, 751, 287-303.
118. Karius, T.; Schnekenburger, M.; Dicato, M.; Diederich, M. MicroRNAs in cancer management and their modulation by dietary agents. Biochem. Pharmacol. 2012, 83, 1591-1601.
119. Zhang, J.; Du, Y.; Wu, C.; Ren, X.; Ti, X.; Shi, J.; Zhao, F.; Yin, H. Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186* signaling pathway. Oncol. Rep. 2010, 24, 1217-1223.
120. Zhang, J.; Zhang, T.; Ti, X.; Shi, J.; Wu, C.; Ren, X.; Yin, H. Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway. Biochem. Biophys. Res. Commun. 2010, 399, 1-6.
121. Mudduluru, G.; George-William, J. N.; Muppala, S.; Asangani, I. A.; Kumarswamy, R.; Nelson, L. D.; Allgayer, H. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci. Rep. 2011, 31, 185-197.
122. Fix, L. N.; Shah, M.; Efferth, T.; Farwell, M. A.; Zhang, B. MicroRNA expression profile of MCF-7 human breast cancer cells and the effect of green tea polyphenon-60. Cancer Genomics Proteomics 2010, 7, 261-277.
123. Siddiqui, I. A.; Asim, M.; Hafeez, B. B.; Adhami, V. M.; Tarapore, R. S.; Mukhtar, H. Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J. 2011, 25, 1198-1207.
124. Iorio, M. V.; Croce, C. M. MicroRNAs in cancer: small molecules with a huge impact. J. Clin. Oncol. 2009, 27, 5848-5856.
125. Jin, Y.; Zou, X.; Feng, X. 3,3'-Diindolylmethane negatively regulates Cdc25A and induces a G2/M arrest by modulation of microRNA 21 in human breast cancer cells. Anticancer Drugs 2010, 21, 814-822.
126. Tili, E.; Michaille, J. J.; Alder, H.; Volinia, S.; Delmas, D.; Latruffe, N.; Croce, C. M. Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFbeta signaling pathway in SW480 cells. Biochem. Pharmacol. 2010, 80, 2057-2065.
127. Sheedy, F. J.; Palsson-McDermott, E.; Hennessy, E. J.; Martin, C.; O'Leary, J. J.; Ruan, Q.; Johnson, D. S.; Chen, Y.; O'Neill, L. A. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol. 2010, 11, 141-147.
128. Gaedicke, S.; Zhang, X.; Schmelzer, C.; Lou, Y.; Doering, F.; Frank, J.; Rimbach, G. Vitamin E dependent microRNA regulation in rat liver. FEBS Lett. 2008, 582, 3542-3546.
129. Davis, C. D.; Ross, S. A. Evidence for dietary regulation of microRNA expression in cancer cells. Nutr. Rev. 2008, 66, 477-482.
130. Izzotti, A.; Larghero, P.; Cartiglia, C.; Longobardi, M.; Pfeffer, U.; Steele, V. E.; De Flora, S. Modulation of microRNA expression by budesonide, phenethyl isothiocyanate and cigarette smoke in mouse liver and lung. Carcinogenesis 2010, 31, 894-901.
131. Hu, S.; Dong, T. S.; Dalal, S. R.; Wu, F.; Bissonnette, M.; Kwon, J. H.; Chang, E. B. The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer. PLoS One 2011, 6, e16221.
132. Wu, N.; Wu, G. C.; Hu, R.; Li, M.; Feng, H. Ginsenoside Rh2 inhibits glioma cell proliferation by targeting microRNA-128. Acta Pharmacol. Sin. 2011, 32, 345-353.
133. Izzotti, A.; Longobardi, M.; Cartiglia, C.; Anzuini, F.; Arrigo, P.; Fazzi, E.; Orcesi, S.; Piana, R. L.; Pulliero, A. Different mutations in three prime repair exonuclease 1 and ribonuclease H2 genes affect clinical features in Aicardi-Goutieres syndrome. J. Child Neurol. 2012, 27, 51-60.
134. Soltanian, S.; Matin, M. M. Cancer stem cells and cancer therapy. Tumour Biol. 2011, 32, 425-440.
135. Fang, D. D.; Wen, D.; Xu, Y. Identification of cancer stem cells provides novel tumor models for drug discovery. Front Med. 2012, 6, 112-121.
136. Kim, Y. S.; Farrar, W.; Colburn, N. H.; Milner, J. A. Cancer stem cells: potential target for bioactive food components. J. Nutr. Biochem. 2012, 23, 691-698.
137. Almanaa, T. N.; Geusz, M. E.; Jamasbi, R. J. Effects of curcumin on stem-like cells in human esophageal squamous carcinoma cell lines. BMC Complement Altern. Med. 2012, 12, 195.
138. Fong, D.; Yeh, A.; Naftalovich, R.; Choi, T. H.; Chan, M. M. Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line: towards targeting of cancer stem cells with phytochemicals. Cancer Lett. 2010, 293, 65-72.
139. Lim, K. J.; Bisht, S.; Bar, E. E.; Maitra, A.; Eberhart, C. G. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol. Ther. 2011, 11, 464-473.
140. Kakarala, M.; Brenner, D. E.; Korkaya, H.; Cheng, C.; Tazi, K.; Ginestier, C.; Liu, S.; Dontu, G.; Wicha, M. S. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res. Treat. 2010, 122, 777-785.
141. Kanwar, S. S.; Yu, Y.; Nautiyal, J.; Patel, B. B.; Padhye, S.; Sarkar, F. H.; Majumdar, A. P. Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells. Pharm. Res. 2011, 28, 827-838.
142. Lin, L.; Liu, Y.; Li, H.; Li, P. K.; Fuchs, J.; Shibata, H.; Iwabuchi, Y.; Lin, J. Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030. Br. J. Cancer 2011, 105, 212-220.
143. Joshua, B.; Kaplan, M. J.; Doweck, I.; Pai, R.; Weissman, I. L.; Prince, M. E.; Ailles, L. E. Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness. Head Neck 2012, 34, 42-49.
144. Ryu, M. J.; Cho, M.; Song, J. Y.; Yun, Y. S.; Choi, I. W.; Kim, D. E.; Park, B. S.; Oh, S. Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochem. Biophys. Res. Commun. 2008, 377, 1304-1308.
145. Wang, Z.; Zhang, Y.; Banerjee, S.; Li, Y.; Sarkar, F. H. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer 2006, 106, 2503-2513.
146. Slusarz, A.; Shenouda, N. S.; Sakla, M. S.; Drenkhahn, S. K.; Narula, A. S.; MacDonald, R. S.; Besch-Williford, C. L.; Lubahn, D. B. Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer. Cancer Res. 2010, 70, 3382-3390.
147. Hossain, M. M.; Banik, N. L.; Ray, S. K. Synergistic anti-cancer mechanisms of curcumin and paclitaxel for growth inhibition of human brain tumor stem cells and LN18 and U138MG cells. Neurochem. Int. 2012, 61, 1102-1113.
148. Ju, J.; Hong, J.; Zhou, J. N.; Pan, Z.; Bose, M.; Liao, J.; Yang, G. Y.; Liu, Y. Y.; Hou, Z.; Lin, Y.; Ma, J.; Shih, W. J.; Carothers, A. M.; Yang, C. S. Hibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res. 2005, 65, 10623-10631.
149. Kim, J.; Zhang, X.; Rieger-Christ, K. M.; Summerhayes, I. C.; Wazer, D. E.; Paulson, K. E.; Yee, A. S. Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1. J. Biol. Chem. 2006, 281, 10865-10875.
150. Tang, S. N.; Fu, J.; Nall, D.; Rodova, M.; Shankar, S.; Srivastava, R. K. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. Int. J. Cancer 2012, 131, 30-40.
151. Li, Y.; Wang, Z.; Kong, D.; Li, R.; Sarkar, S. H.; Sarkar, F. H. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells. J. Biol. Chem. 2008, 283, 27707-27716.
152. Su, Y.; Simmen, R. C. Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates beta-catenin signaling in mammary epithelial cells. Carcinogenesis 2009, 30, 331-339.
153. Zhang, L.; Li, L.; Jiao, M.; Wu, D.; Wu, K.; Li, X.; Zhu, G.; Yang, L.; Wang, X.; Hsieh, J. T.; He, D. Genistein inhibits the stemness properties of prostate cancer cells through targeting Hedgehog-Gli1 pathway. Cancer Lett. 2012, 323, 48-57.
154. Semov, A.; Iourtchenco, L.; Liu, L. F.; Li, S.; Xu, Y.; Su, X.; Muyjnek, E.; Kiselev, V.; Alakhov, V. Diindolilmethane (DIM) selectively inhibits cancer stem cells. Biochem. Biophys. Res. Commun. 2012, 424, 45-51.
155. Aggarwal, B. B.; Sung, B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol. Sci. 2009, 30, 85-94.
156. Hope, C.; Planutis, K.; Planutiene, M.; Moyer, M. P.; Johal, K. S.; Woo, J.; Santoso, C.; Hanson, J. A.; Holcombe, R. F. Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention. Mol. Nutr. Food Res. 2008, 52(Suppl 1), S52-61.
157. Lu, K. H.; Chen, Y. W.; Tsai, P. H.; Tsai, M. L.; Lee, Y. Y.; Chiang, C. Y.; Kao, C. L.; Chiou, S. H.; Ku, H. H.; Lin, C. H.; Chen, Y. J. Evaluation of radiotherapy effect in resveratrol-treated medulloblastoma cancer stem-like cells. Childs Nerv. Syst. 2009, 25, 543-550.
158. Kallifatidis, G.; Rausch, V.; Baumann, B.; Apel, A.; Beckermann, B. M.; Groth, A.; Mattern, J.; Li, Z.; Kolb, A.; Moldenhauer, G.; Altevogt, P.; Wirth, T.; Werner, J.; Schemmer, P.; Buchler, M. W.; Salnikov, A. V.; Herr, I. Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut 2009, 58, 949-963.
159. Khor, T. O.; Hu, R.; Shen, G.; Jeong, W. S.; Hebbar, V.; Chen, C.; Xu, C.; Nair, S.; Reddy, B.; Chada, K.; Kong, A. N. Pharma-cogenomics of cancer chemopreventive isothiocyanate compound sulforaphane in the intestinal polyps of ApcMin/+ mice. Biopharm. Drug Dispos. 2006, 27, 407-420.
160. Lee, D. H.; Iwanski, G. B.; Thoennissen, N. H. Cucurbitacin: ancient compound shedding new light on cancer treatment. ScientificWorldJournal, 2010, 10, 413-418.
161. Blaskovich, M. A.; Sun, J.; Cantor, A.; Turkson, J.; Jove, R.; Sebti, S. M. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res. 2003, 63, 1270-1279.
162. Chen, Y. W.; Chen, K. H.; Huang, P. I.; Chen, Y. C.; Chiou, G. Y.; Lo, W. L.; Tseng, L. M.; Hsu, H. S.; Chang, K. W.; Chiou, S. H. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma-derived CD44(+)ALDH1(+) cells. Mol. Cancer Ther. 2010, 9, 2879-2892.
163. Chang, C. J.; Chiang, C. H.; Song, W. S.; Tsai, S. K.; Woung, L. C.; Chang, C. H.; Jeng, S. Y.; Tsai, C. Y.; Hsu, C. C.; Lee, H. F.; Huang, C. S.; Yung, M. C.; Liu, J. H.; Lu, K. H. Inhibition of phosphorylated STAT3 by cucurbitacin I enhances chemoradiosensitivity in medulloblastoma-derived cancer stem cells. Childs Nerv. Syst. 2012, 28, 363-373.
164. Hsu, H. S.; Huang, P. I.; Chang, Y. L.; Tzao, C.; Chen, Y. W.; Shih, H. C.; Hung, S. C.; Chen, Y. C.; Tseng, L. M.; Chiou, S. H. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells. Cancer 2011, 117, 2970-2985.
165. Tang, F. Y.; Shih, C. J.; Cheng, L. H.; Ho, H. J.; Chen, H. J. Lycopene inhibits growth of human colon cancer cells via suppression of the Akt signaling pathway. Mol. Nutr. Food Res. 2008, 52, 646-654.
166. Palmer, H. G.; Gonzalez-Sancho, J. M.; Espada, J.; Berciano, M. T.; Puig, I.; Baulida, J.; Quintanilla, M.; Cano, A.; de Herreros, A. G.; Lafarga, M.; Munoz, A. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J. Cell Biol. 2001, 154, 369-387.
167. Danilenko, M.; Studzinski, G. P. Enhancement by other compounds of the anti-cancer activity of vitamin D(3) and its analogs. Exp. Cell Res. 2004, 298, 339-358.
168. Blomberg Jensen, M.; Jorgensen, A.; Nielsen, J. E.; Steinmeyer, A.; Leffers, H.; Juul, A.; Rajpert-De Meyts, E. Vitamin d metabolism and effects on pluripotency genes and cell differentiation in testicular germ cell tumors in vitro and in vivo. Neoplasia 2012, 14, 952-963.
169. Hsiao, W. C.; Sung, S. Y.; Liao, C. H.; Wu, H. C.; Hsieh, C. L. Vitamin D3-inducible mesenchymal stem cell-based delivery of conditionally replicating adenoviruses effectively targets renal cell carcinoma and inhibits tumor growth. Mol. Pharm. 2012, 9, 1396-1408.
170. Chen, M.; Hildebrandt, M. A.; Clague, J.; Kamat, A. M.; Picornell, A.; Chang, J.; Zhang, X.; Izzo, J.; Yang, H.; Lin, J.; Gu, J.; Chanock, S.; Kogevinas, M.; Rothman, N.; Silverman, D. T.; Garcia-Closas, M.; Grossman, H. B.; Dinney, C. P.; Malats, N.; Wu, X. Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer. Cancer Prev. Res. (Phila) 2010, 3, 1235-1245.
171. Takebe, N.; Harris, P. J.; Warren, R. Q.; Ivy, S. P. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat. Rev. Clin. Oncol. 2011, 8, 97-106.
172. Montales, M. T.; Rahal, O. M.; Kang, J.; Rogers, T. J.; Prior, R. L.; Wu, X.; Simmen, R. C. Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cells. Carcinogenesis 2012, 33, 652-660.
173. Kao, C. L.; Huang, P. I.; Tsai, P. H.; Tsai, M. L.; Lo, J. F.; Lee, Y. Y.; Chen, Y. J.; Chen, Y. W.; Chiou, S. H. Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor. Int. J. Radiat. Oncol. Biol. Phys. 2009, 74, 219-228.